Annual ROE
-84.76%
-37.89%-80.84%
December 31, 2023
Summary
- As of February 7, 2025, ALXO annual return on equity is -84.76%, with the most recent change of -37.89% (-80.84%) on December 31, 2023.
- During the last 3 years, ALXO annual ROE has fallen by -63.46% (-297.93%).
- ALXO annual ROE is now -297.93% below its all-time high of -21.30%, reached on December 31, 2020.
Performance
ALXO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-93.02%
+7.54%+7.50%
September 30, 2024
Summary
- As of February 7, 2025, ALXO quarterly return on equity is -93.02%, with the most recent change of +7.54% (+7.50%) on September 30, 2024.
- Over the past year, ALXO quarterly ROE has dropped by -27.03% (-40.96%).
- ALXO quarterly ROE is now -101.33% below its all-time high of 6972.10%, reached on December 31, 2019.
Performance
ALXO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ALXO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.8% | -41.0% |
| 3 y3 years | -297.9% | -271.0% |
| 5 y5 years | +43.5% | -408.6% |
ALXO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -268.7% | at low | -337.9% | +7.5% |
| 5 y | 5-year | -297.9% | +80.5% | -101.3% | +7.5% |
| alltime | all time | -297.9% | +80.5% | -101.3% | +7.5% |
ALX Oncology Holdings ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -93.02%(-7.5%) |
| Jun 2024 | - | -100.56%(+11.2%) |
| Mar 2024 | - | -90.41%(+14.1%) |
| Dec 2023 | -84.76%(+80.8%) | -79.26%(+20.1%) |
| Sep 2023 | - | -65.99%(+27.0%) |
| Jun 2023 | - | -51.97%(+11.4%) |
| Mar 2023 | - | -46.65%(+14.3%) |
| Dec 2022 | -46.87% | -40.81%(+10.3%) |
| Sep 2022 | - | -37.01%(+17.9%) |
| Jun 2022 | - | -31.38%(+25.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -25.07%(+18.0%) |
| Dec 2021 | -22.99%(+7.9%) | -21.24%(+17.9%) |
| Sep 2021 | - | -18.02%(+14.1%) |
| Jun 2021 | - | -15.79%(-13.7%) |
| Mar 2021 | - | -18.29%(-12.9%) |
| Dec 2020 | -21.30%(-95.1%) | -20.99%(-33.3%) |
| Sep 2020 | - | -31.47%(-28.0%) |
| Jun 2020 | - | -43.69%(+5.5%) |
| Mar 2020 | - | -41.40%(-100.6%) |
| Dec 2019 | -433.45%(+189.0%) | 6972.10% |
| Dec 2018 | -149.98% | - |
FAQ
- What is ALX Oncology Holdings annual return on equity?
- What is the all time high annual ROE for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual ROE year-on-year change?
- What is ALX Oncology Holdings quarterly return on equity?
- What is the all time high quarterly ROE for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly ROE year-on-year change?
What is ALX Oncology Holdings annual return on equity?
The current annual ROE of ALXO is -84.76%
What is the all time high annual ROE for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual return on equity is -21.30%
What is ALX Oncology Holdings annual ROE year-on-year change?
Over the past year, ALXO annual return on equity has changed by -37.89% (-80.84%)
What is ALX Oncology Holdings quarterly return on equity?
The current quarterly ROE of ALXO is -93.02%
What is the all time high quarterly ROE for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly return on equity is 6972.10%
What is ALX Oncology Holdings quarterly ROE year-on-year change?
Over the past year, ALXO quarterly return on equity has changed by -27.03% (-40.96%)